{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:51:59Z","timestamp":1795020719017,"version":"4.10.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Andes orthohantavirus (ANDV) is a deadly pathogen that causes hantavirus cardiopulmonary syndrome (HCPS), which is a severe disease characterized by respiratory failure and high mortality rates (~30\u201340%). While previous studies have shown that neutralizing antibodies have a critical role in survival, the contribution of the Fc-mediated effector functions remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a serological profiling of acute HCPS patients and survivors, analyzing antibody types, subtypes, and neutralization capacity targeting ANDV glycoproteins (Gn and GnGc). Fc-mediated effector functions, which are key to defining antibody-mediated correlates of protection, were analyzed using Fc\u03b3R reporter signaling assays, antibody-dependent NK cell activation, and antibody-dependent complement deposition (ADCD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Acute HCPS patients who developed moderate disease exhibited significantly higher IgG levels against the Gn glycoprotein and stronger Fc-mediated effector functions, including antibody-dependent NK cell activation and ADCD against glycoproteins, compared to the more severe cases. Surviving acute patients showed elevated IgG and IgM responses against Gn. In survivors, polyfunctional non-neutralizing IgG activities persisted for years after infection and were more pronounced against the GnGc complex than Gn alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In summary, our study reveals the existence of functional diversity in the humoral immune response to ANDV glycoprotein during HCPS, which can be associated with protective responses and may contribute to a long-lasting immune response to restrict ANDV infection. These findings identify Fc effector functions as important correlates of protection and provide valuable insights for the design of next-generation vaccines and therapeutics against hantaviruses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1730584","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:36:58Z","timestamp":1780637818000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Polyfunctional antibody signature defines protection in Andes hantavirus survival"],"prefix":"10.3389","volume":"17","author":[{"given":"Felipe","family":"Bravo","sequence":"first","affiliation":[{"name":"Departamento de Microbiolog\u00eda, Facultad de Ciencias Biol\u00f3gicas, Universidad de Concepci\u00f3n","place":["Concepci\u00f3n, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tybbysay P.","family":"Salinas","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]},{"name":"Departamento de Investigaci\u00f3n de Enfermedades Emergentes y Zoon\u00f3ticas, Instituto Conmemorativo Gorgas de estudios de la Salud","place":["Ciudad de Panam\u00e1, Panama"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Kossack","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge T.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Giacaman","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda Molecular, Hospital Base de Valdivia","place":["Valdivia, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Quevedo","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Biol\u00f3gicas, Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad de Concepci\u00f3n","place":["Concepci\u00f3n, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Fuller","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Biol\u00f3gicas, Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad de Concepci\u00f3n","place":["Concepci\u00f3n, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farides","family":"Saavedra","sequence":"additional","affiliation":[{"name":"Departamento de Microbiolog\u00eda, Facultad de Ciencias Biol\u00f3gicas, Universidad de Concepci\u00f3n","place":["Concepci\u00f3n, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Aguilera-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Aguilera","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Biol\u00f3gicas, Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad de Concepci\u00f3n","place":["Concepci\u00f3n, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Riquelme","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Rioseco","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]},{"name":"Hospital Puerto Montt Dr. Eduardo Sch\u00fctz Schroeder","place":["Puerto Montt, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Calvo","sequence":"additional","affiliation":[{"name":"Instituto de Medicina, Facultad de Medicina, Universidad Austral de Chile","place":["Valdivia, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A.","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Ichor Biologics LLC","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Pascale","sequence":"additional","affiliation":[{"name":"Departamento de Investigaci\u00f3n de Enfermedades Emergentes y Zoon\u00f3ticas, Instituto Conmemorativo Gorgas de estudios de la Salud","place":["Ciudad de Panam\u00e1, Panama"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blas","family":"Armi\u00e9n","sequence":"additional","affiliation":[{"name":"Departamento de Investigaci\u00f3n de Enfermedades Emergentes y Zoon\u00f3ticas, Instituto Conmemorativo Gorgas de estudios de la Salud","place":["Ciudad de Panam\u00e1, Panama"]},{"name":"Sistema Nacional de Investigaci\u00f3n, Secretaria Nacional de Ciencia y Tecnolog\u00eda","place":["Ciudad de Panam\u00e1, Panama"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"Navarrete","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda Molecular, Hospital Base de Valdivia","place":["Valdivia, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Garrido","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]},{"name":"Ichor Biologics LLC","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ines","family":"Barria","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad San Sebasti\u00e1n","place":["Puerto Montt, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25446","article-title":"Epidemiological description, case-fatality rate, and trends of hantavirus pulmonary syndrome: 9 years of surveillance in Argentina","volume":"91","author":"Alonso","year":"2019","journal-title":"J Med Virol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3066","article-title":"Uncovering the mysteries of hantavirus infections","volume":"11","author":"Vaheri","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1086\/516786","article-title":"Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile","volume":"195","author":"Ferr\u00e9s","year":"2007","journal-title":"J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1112.050501","article-title":"Person-to-person transmission of andes virus","volume":"11","author":"Martinez","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00482-20","article-title":"Humoral immunity to hantavirus infection","volume":"5","author":"Engdahl","year":"2020","journal-title":"mSphere"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3201\/eid1201.050930","article-title":"Neutralizing antibodies in survivors of sin nombre and andes hantavirus infection","volume":"12","author":"Valdivieso","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2011.09.017","article-title":"Sin nombre virus\u2013specific immunoglobulin m and g kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome","volume":"202","author":"MacNeil","year":"2010","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1086\/315657","article-title":"Humoral immune responses in the hantavirus cardiopulmonary syndrome","volume":"182","author":"Bharadwaj","year":"2000","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00028-20","article-title":"Neutralizing monoclonal antibodies against the gn and the gc of the andes virus glycoprotein spike complex protect from virus challenge in a preclinical hamster model","volume":"11","author":"Duehr","year":"2020","journal-title":"mBio"},{"key":"B10","doi-asserted-by":"publisher","first-page":"109453","DOI":"10.1016\/j.celrep.2021.109086","article-title":"Broad and potently neutralizing monoclonal antibodies isolated from human survivors of new world hantavirus infection","volume":"36","author":"Engdahl","year":"2021","journal-title":"Cell Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat6420","article-title":"Two recombinant human monoclonal antibodies that protect against lethal andes hantavirus infection in vivo","volume":"10","author":"Garrido","year":"2018","journal-title":"Sci Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3201\/eid2710.210735","article-title":"Therapeutic efficacy of human monoclonal antibodies against Andes virus infection in Syrian hamsters","volume":"27","author":"Williamson","year":"2021","journal-title":"Emerging Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7554\/elife.81743","article-title":"Antigenic mapping and functional characterization of human new world hantavirus neutralizing antibodies","volume":"12","author":"Engdahl","year":"2023","journal-title":"eLife"},{"key":"B14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc? receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3201\/eid0602.000213","article-title":"Sin nombre virus (snv) ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome","volume":"6","author":"Bostik","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103765","article-title":"Delayed viral clearance despite high number of activated t cells during the acute phase in argentinean patients with hantavirus pulmonary syndrome","volume":"75","author":"Iglesias","year":"2022","journal-title":"eBioMedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.796481","article-title":"Sustained antibody-dependent nk cell functions in mild covid-19 outpatients during convalescence","volume":"13","author":"Fuentes-Villalobos","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.08.023","article-title":"The hantavirus surface glycoprotein lattice and its fusion control mechanism","volume":"183","author":"Serris","year":"2020","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.100","article-title":"Sars\u2010cov\u20102 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr Protoc Microbiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88226","article-title":"Enhanced fcgr2a and fcgr3a signaling by hiv viremic controller igg","volume":"2","author":"Alvarez","year":"2017","journal-title":"JCI Insight"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01851","article-title":"A sample-sparing multiplexed adcp assay","volume":"10","author":"Butler","year":"2019","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"112630","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J Immunol Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.virusres.2013.12.040","article-title":"Serological diagnosis with recombinant N antigen for hantavirus infection","volume":"187","author":"Yoshimatsu","year":"2014","journal-title":"Virus Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13322","article-title":"Immune response during hantavirus diseases: implications for immunotherapies and vaccine design","volume":"163","author":"Saavedra","year":"2021","journal-title":"Immunology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/v17050723","article-title":"Evaluating neutralizing antibodies in hantavirus-infected patients using authentic virus and recombinant vesicular stomatitis virus systems","volume":"17","author":"Shrivastava-Ranjan","year":"2025","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40699-8","article-title":"Antibody-mediated nk cell activation as a correlate of immunity against influenza infection","volume":"14","author":"Boudreau","year":"2023","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13393","article-title":"Fc\u2010fc\u03b3r interactions during infections: from neutralizing antibodies to antibody\u2010dependent enhancement","volume":"328","author":"Edgar","year":"2024","journal-title":"Immunol Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01590","article-title":"Non-neutralizing antibodies directed against hiv and their functions","volume":"8","author":"Mayr","year":"2017","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"Cd107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz364","article-title":"Survivors of ebola virus disease develop polyfunctional antibody responses","volume":"221","author":"Gunn","year":"2020","journal-title":"J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92750","article-title":"Fc functional antibodies in humans with severe h7n9 and seasonal influenza","volume":"2","author":"Vanderven","year":"2017","journal-title":"JCI Insight"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00373-09","article-title":"Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus","volume":"83","author":"Safronetz","year":"2009","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz657","article-title":"Antibody-dependent natural killer cell activation after Ebola vaccination","volume":"223","author":"Wagstaffe","year":"2021","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41541-024-00959-0","article-title":"Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine","volume":"9","author":"Casazza","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-022-00175-7","article-title":"Fc receptors and the diversity of antibody responses to hiv infection and vaccination","volume":"23","author":"Lin","year":"2022","journal-title":"Genes Immun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106091","article-title":"Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to puumala virus infection","volume":"124","author":"Clark","year":"2026","journal-title":"eBioMedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jmv.1890430108","article-title":"Class and subclass distribution of hantavirus?specific serum antibodies at different times after the onset of nephropathia epidemica","volume":"43","author":"Groen","year":"1994","journal-title":"J Med Virol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.603228","article-title":"Cytokine profiles and antibody response associated to choclo orthohantavirus infection","volume":"12","author":"Salinas","year":"2021","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human igg receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.03.255","article-title":"Molecular properties of human igg subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases","volume":"67","author":"Irani","year":"2015","journal-title":"Mol Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1113425","article-title":"Immune-correlates analysis of an hiv-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140925","article-title":"Igg3 collaborates with igg1 and iga to recruit effector function in rv144 vaccinees","volume":"5","author":"Fischinger","year":"2020","journal-title":"JCI Insight"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01457","article-title":"Influenza and antibody-dependent cellular cytotoxicity","volume":"10","author":"Von Holle","year":"2019","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.cell.2021.02.026","article-title":"Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection","volume":"184","author":"Winkler","year":"2021","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41392-021-00759-1","article-title":"Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.082","article-title":"Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection","volume":"35","author":"De Vries","year":"2017","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm3151","article-title":"Antibody fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection","volume":"14","author":"Dias","year":"2022","journal-title":"Sci Transl Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115613","article-title":"Anti-dengue virus antibodies that elicit complement-mediated lysis of zika virion correlate with protection from severe dengue disease","volume":"44","author":"Dias","year":"2025","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz005","article-title":"Serum markers associated with severity and outcome of hantavirus pulmonary syndrome","volume":"219","author":"Maleki","year":"2019","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/v11080680","article-title":"Deletions in genes participating in innate immune response modify the clinical course of andes orthohantavirus infection","volume":"11","author":"Ribeiro","year":"2019","journal-title":"Viruses"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2011.573500","article-title":"Complement activation in puumala hantavirus infection correlates with disease severity","volume":"44","author":"Sane","year":"2012","journal-title":"Ann Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/bf01319001","article-title":"The humoral response to puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays","volume":"130","author":"Lundkvist","year":"1993","journal-title":"Arch Virol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3201\/eid1003.020821","article-title":"Neutralizing antibodies and Sin Nombre virus RNA after recovery from Hantavirus cardiopulmonary syndrome","volume":"10","author":"Ye","year":"2004","journal-title":"Emerging Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12713","article-title":"Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome","volume":"151","author":"Garc\u00eda","year":"2017","journal-title":"Immunology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009843","article-title":"Hantavirus infection-induced b cell activation elevates free light chains levels in circulation","volume":"17","author":"Hepojoki","year":"2021","journal-title":"PloS Pathog"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/v15112266","article-title":"Presence and persistence of Andes virus RNA in human semen","volume":"15","author":"Z\u00fcst","year":"2023","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01359-1","article-title":"Fc-\u03b3r-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of sars-cov-2","volume":"8","author":"Mackin","year":"2023","journal-title":"Nat Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730584\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:36:59Z","timestamp":1780637819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730584\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2026.1730584"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1730584","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1730584.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"1730584"}}